Vin Bange discusses how data privacy laws relate to genetic and health data, with Verdict

Genomics and biotechnology company 23andMe has announced that it is going public through a deal with Virgin.

Launched in 2006, 23andMe offers genetic testing services to consumers. By providing a saliva sample, customers can find out about their ancestry and predisposition to certain health conditions.

Vin comments on the data privacy risks this deal brings, and the business obligations involved with working with genetic data.

Read the full article in Verdict